We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$347M
AUM Growth
-$2.81M
Cap. Flow
-$24.6M
Cap. Flow %
-7.11%
Top 10 Hldgs %
73.11%
Holding
49
New
–
Increased
–
Reduced
1
Closed
3

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$21.8M
2
PRLB icon
Protolabs
PRLB
+$1.36M
3
EXEL icon
Exelixis
EXEL
+$1.24M
4
HON icon
Honeywell
HON
+$212K

Sector Composition

Rank Sector Weight
1 Technology 33.64%
2 Consumer Discretionary 30.16%
3 Healthcare 21.1%
4 Communication Services 12.66%
5 Utilities 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEE icon
26
NextEra Energy
NEE
$185B
$2.74M 0.79%
34,908
– –
LLY icon
27
Eli Lilly
LLY
$1.07T
$2.09M 0.6%
9,044
– –
AMD icon
28
Advanced Micro Devices
AMD
$807B
$1.37M 0.4%
13,308
– –
ABT icon
29
Abbott
ABT
$182B
$1.06M 0.31%
8,976
– –
BMY icon
30
Bristol-Myers Squibb
BMY
$128B
$913K 0.26%
15,425
– –
NSC icon
31
Norfolk Southern
NSC
$77.1B
$860K 0.25%
3,595
– –
COST icon
32
Costco
COST
$422B
$846K 0.24%
1,883
– –
BA icon
33
Boeing
BA
$167B
$838K 0.24%
3,809
– –
JNJ icon
34
Johnson & Johnson
JNJ
$641B
$805K 0.23%
4,986
– –
JPM icon
35
JPMorgan Chase
JPM
$947B
$697K 0.2%
4,261
– –
PFE icon
36
Pfizer
PFE
$141B
$577K 0.17%
13,417
– –
PAYX icon
37
Paychex
PAYX
$41.1B
$541K 0.16%
4,810
– –
TROW icon
38
T. Rowe Price
TROW
$25.5B
$491K 0.14%
2,495
– –
TGT icon
39
Target
TGT
$63.7B
$490K 0.14%
2,140
– –
MRK icon
40
Merck
MRK
$323B
$484K 0.14%
6,442
– –
DE icon
41
Deere & Co
DE
$169B
$472K 0.14%
1,410
– –
NUE icon
42
Nucor
NUE
$56.4B
$431K 0.12%
4,375
– –
CAT icon
43
Caterpillar
CAT
$402B
$326K 0.09%
1,697
– –
IDXX icon
44
Idexx Laboratories
IDXX
$43.9B
$314K 0.09%
505
– –
DUK icon
45
Duke Energy
DUK
$100B
$256K 0.07%
2,626
– –
NOW icon
46
ServiceNow
NOW
$109B
$252K 0.07%
2,025
– –
EXEL icon
47
Exelixis
EXEL
$14B
– –
-58,469
Closed -$1.24M
HON icon
48
Honeywell
HON
$77.9B
– –
-1,061
Closed -$212K
PRLB icon
49
Protolabs
PRLB
$1.85B
– –
-20,385
Closed -$1.36M
1
2

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
KPWG
KFA Private Wealth Group Tysons, Virginia $417M AUM 16.82% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return

Bender Robert & Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Bender Robert & Associates held 49 positions worth $347M, down 0.8% from $349M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Bender Robert & Associates withdrew a net $24.6M in Q4 2021, closing 3 positions and reducing 1 holding. Its most notable exit was Protolabs, an estimated $1.36M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bender Robert & Associates's biggest Q4 2021 reduction was Intuitive Surgical, cutting an estimated $21.8M.
  • Bender Robert & Associates fully exited Protolabs in Q4 2021, selling an estimated $1.36M.
  • Bender Robert & Associates's ten largest holdings make up 73% of its $347M portfolio in Q4 2021.
  • Bender Robert & Associates opened 0 new positions and closed 3 in Q4 2021.
  • Bender Robert & Associates's portfolio value fell 0.8% quarter-over-quarter to $347M.

Based on Bender Robert & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.